Status:
COMPLETED
Antibiotics in Patients With Acute Respiratory Tract Infection With Procalcitonin as Parameter
Lead Sponsor:
Hannover Medical School
Conditions:
Respiratory Tract Infection
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
Antibiotics in patients with acute respiratory tract infections in primary care in consideration of procalcitonin as additive parameter. The purpose of this study is to compare the ordinary manner of...
Eligibility Criteria
Inclusion
- 18 years or older
- Informed consent
- Respiratory tract infection based on the clinical judgement of the primary care physician
Exclusion
- Antibiotic pretreatment in previous 14 days
- Portal hypertension
- Major surgeries or multiple trauma which require hospitalization, in previous 4 weeks
- Autoimmune disease and systemic diseases (lupus erythematodes, wegener´s disease)
- Peritoneal dialysis
- Acute treated or recently operated medullary c-cell-carcinoma, SCLC, carcinoid
- Other inflammatory diseases (e.g. urinary tract infection, pyelonephritis, pancreatitis
Key Trial Info
Start Date :
November 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2008
Estimated Enrollment :
571 Patients enrolled
Trial Details
Trial ID
NCT00688610
Start Date
November 1 2007
End Date
June 1 2008
Last Update
January 28 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Medical School Hannover, Department Pneumology
Hanover, Germany, 30625